Delivery Order SPE2DB20D2104-SPE2DB25FMMUV

Award Date 4/7/25
Potential Completion Date 4/8/25
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,425.94, is a firm fixed-price delivery order for the supply of IBSRELA 50 MG TABLET UU 60S, a medical product. The contract has an ultimate completion date of January 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,973.57 firm-fixed-price delivery order is for the supply of IBSRELA 50 MG TABLET UU 60S, a pharmaceutical product. The contract has an ultimate completion date of March 24, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The award, valued at $4,226.33, is for the delivery of IBSRELA 50 MG TABLET medication. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,763.74 firm fixed-price delivery order is for the medical product "IBSRELA 50 MG TABLET UU 60S" with a completion date of February 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,475.84 firm-fixed-price delivery order is for the pharmaceutical product "IBSRELA 50 MG TABLET UU 60S" and has an ultimate completion date of March 6, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,498.36, is for the delivery of 4561313241 - IBSRELA 50 MG TABLET UU 60S, a pharmaceutical product. The contract is a firm-fixed price delivery order with a completion date of June 22, 2023. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen holds a...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order valued at $17,788.58 for the provision of 4566976306 - IBSRELA 50 MG TABLET UU 60S. The award was issued by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of January 21, 2025. AmerisourceBergen Drug Corp is the prime contractor for this firm fixed-price contract and there is no set-aside designation. The company also holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,490.36 firm fixed-price contract is for the provision of 4566444867 IBSRELA 50 MG TABLET UU 60S medical supplies, and has an ultimate completion date of November 18, 2024. This award is not a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of IBSRELA 50 MG TABLET UU 60S. The contract, with a ceiling value of $6,486.85, is a delivery order type with firm fixed pricing. The period of performance is from the award date of October 11, 2024 through October 15, 2024. This contract award is not designated as a set-aside. AmerisourceBergen has a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,154.53 and is for the delivery of IBSRELA 50 MG TABLET (4567474761) to support federal healthcare programs. It is a firm fixed-price contract with a period of performance through March 6, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMMUV
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order worth $2,444.99 for the supply of IBSRELA 50 MG TABLET UU 60S, a pharmaceutical product. The contract has an ultimate completion date of April 8, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract award does not have a set-aside designation, indicating open competition.

Generated 7/7/25, 1:18 PM